Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 44

1.

Droxidopa for the treatment of neurogenic orthostatic hypotension in neurodegenerative diseases.

Pérez-Lloret S, Quarracino C, Otero-Losada M, Rascol O.

Expert Opin Pharmacother. 2019 Apr;20(6):635-645. doi: 10.1080/14656566.2019.1574746. Epub 2019 Feb 7. Review.

PMID:
30730771
2.

Chemical pharmacotherapy for the treatment of orthostatic hypotension.

Cheshire WP.

Expert Opin Pharmacother. 2019 Feb;20(2):187-199. doi: 10.1080/14656566.2018.1543404. Epub 2018 Nov 8. Review.

PMID:
30376728
3.

Is Technology for Orthostatic Hypotension Ready for Primetime?

Sarafis ZK, Monga AK, Phillips AA, Krassioukov AV.

PM R. 2018 Sep;10(9 Suppl 2):S249-S263. doi: 10.1016/j.pmrj.2018.04.011. Review.

PMID:
30269810
4.

The association between orthostatic hypotension and dementia: A meta-analysis of prospective cohort studies.

Min M, Shi T, Sun C, Liang M, Zhang Y, Wu Y, Sun Y.

Int J Geriatr Psychiatry. 2018 Dec;33(12):1541-1547. doi: 10.1002/gps.4964. Epub 2018 Sep 24. Review.

PMID:
30247788
5.

Orthostatic Hypotension: JACC State-of-the-Art Review.

Freeman R, Abuzinadah AR, Gibbons C, Jones P, Miglis MG, Sinn DI.

J Am Coll Cardiol. 2018 Sep 11;72(11):1294-1309. doi: 10.1016/j.jacc.2018.05.079. Review.

6.

Orthostatic Hypotension in the Hypertensive Patient.

Biaggioni I.

Am J Hypertens. 2018 Nov 13;31(12):1255-1259. doi: 10.1093/ajh/hpy089. Review.

PMID:
29982276
7.

Evaluating the effectiveness of atomoxetine for the treatment of primary orthostatic hypotension in adults.

Patel H, Simpson A, Palevoda G, Hale GM.

J Clin Hypertens (Greenwich). 2018 Apr;20(4):794-797. doi: 10.1111/jch.13260. Epub 2018 Mar 22. Review. No abstract available.

8.

Evidence-based treatment of neurogenic orthostatic hypotension and related symptoms.

Eschlböck S, Wenning G, Fanciulli A.

J Neural Transm (Vienna). 2017 Dec;124(12):1567-1605. doi: 10.1007/s00702-017-1791-y. Epub 2017 Oct 22. Review. Erratum in: J Neural Transm (Vienna). 2017 Nov 28;:.

9.

Orthostatic hypotension for the cardiologist.

Mar PL, Raj SR.

Curr Opin Cardiol. 2018 Jan;33(1):66-72. doi: 10.1097/HCO.0000000000000467. Review.

10.

Prevalence, risk factors, and prognosis of orthostatic hypotension in diabetic patients: A systematic review and meta-analysis.

Zhou Y, Ke SJ, Qiu XP, Liu LB.

Medicine (Baltimore). 2017 Sep;96(36):e8004. doi: 10.1097/MD.0000000000008004. Review.

11.

Orthostatic Hypotension: A Practical Approach to Investigation and Management.

Arnold AC, Raj SR.

Can J Cardiol. 2017 Dec;33(12):1725-1728. doi: 10.1016/j.cjca.2017.05.007. Epub 2017 May 17. Review.

12.

Management of Supine Hypertension Complicating Neurogenic Orthostatic Hypotension.

Baker J, Kimpinski K.

CNS Drugs. 2017 Aug;31(8):653-663. doi: 10.1007/s40263-017-0453-9. Review.

PMID:
28702747
13.

Orthostatic hypotension: A review.

Joseph A, Wanono R, Flamant M, Vidal-Petiot E.

Nephrol Ther. 2017 Apr;13 Suppl 1:S55-S67. doi: 10.1016/j.nephro.2017.01.003. Review.

PMID:
28577744
14.

Is orthostatic hypotension related to falling? A meta-analysis of individual patient data of prospective observational studies.

Hartog LC, Schrijnders D, Landman GWD, Groenier K, Kleefstra N, Bilo HJG, van Hateren KJJ.

Age Ageing. 2017 Jul 1;46(4):568-575. doi: 10.1093/ageing/afx024. Review.

15.

Cardiovascular Safety of Droxidopa in Patients With Symptomatic Neurogenic Orthostatic Hypotension.

White WB, Hauser RA, Rowse GJ, Ziemann A, Hewitt LA.

Am J Cardiol. 2017 Apr 1;119(7):1111-1115. doi: 10.1016/j.amjcard.2016.11.066. Epub 2017 Jan 6. Review.

16.

The Treatment of Primary Orthostatic Hypotension.

Hale GM, Valdes J, Brenner M.

Ann Pharmacother. 2017 May;51(5):417-428. doi: 10.1177/1060028016689264. Epub 2017 Jan 16. Review.

PMID:
28092986
17.

The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension.

Gibbons CH, Schmidt P, Biaggioni I, Frazier-Mills C, Freeman R, Isaacson S, Karabin B, Kuritzky L, Lew M, Low P, Mehdirad A, Raj SR, Vernino S, Kaufmann H.

J Neurol. 2017 Aug;264(8):1567-1582. doi: 10.1007/s00415-016-8375-x. Epub 2017 Jan 3. Review.

18.

New Horizons in orthostatic hypotension.

Frith J, Parry SW.

Age Ageing. 2017 Mar 1;46(2):168-174. doi: 10.1093/ageing/afw211. Review.

PMID:
27864240
19.

'Under pressure': is there a link between orthostatic hypotension and cognitive impairment in α-synucleinopathies?

Udow SJ, Robertson AD, MacIntosh BJ, Espay AJ, Rowe JB, Lang AE, Masellis M.

J Neurol Neurosurg Psychiatry. 2016 Dec;87(12):1311-1321. doi: 10.1136/jnnp-2016-314123. Epub 2016 Sep 9. Review.

PMID:
27613160
20.

Neurogenic orthostatic hypotension and supine hypertension in Parkinson's disease and related synucleinopathies: prioritisation of treatment targets.

Espay AJ, LeWitt PA, Hauser RA, Merola A, Masellis M, Lang AE.

Lancet Neurol. 2016 Aug;15(9):954-966. doi: 10.1016/S1474-4422(16)30079-5. Review.

PMID:
27478953

Supplemental Content

Loading ...
Support Center